Mitsubishi Tanabe Pharma Corp (4508.T)
4508.T on Tokyo Stock Exchange
1,898JPY
11:30am IST
1,898JPY
11:30am IST
Change (% chg)
¥15 (+0.80%)
¥15 (+0.80%)
Prev Close
¥1,883
¥1,883
Open
¥1,900
¥1,900
Day's High
¥1,907
¥1,907
Day's Low
¥1,888
¥1,888
Volume
1,323,800
1,323,800
Avg. Vol
1,336,902
1,336,902
52-wk High
¥2,748
¥2,748
52-wk Low
¥1,858
¥1,858
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 94,542.00 | 10.441 |
| Dec | 125,957.00 | 39.731 | |
| Sep | 105,648.00 | 22.905 | |
| Jun | 107,708.00 | 30.270 | |
| FY 2017 | Mar '17 | 99,625.00 | 19.728 |
| Dec | 120,237.00 | 42.602 | |
| Sep | 98,622.00 | 25.658 | |
| Jun | 105,493.00 | 39.044 | |
| FY 2016 | Mar '16 | 91,233.00 | 0.185 |
| Dec | 132,466.00 | 41.871 | |
| Sep | 103,410.00 | 30.692 | |
| Jun | 98,655.00 | 32.969 |
*Note: Units in Millions ofYen
**Note: Units in Yen
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 2 | 106,700.00 | 107,400.00 | 106,000.00 | -- |
| Quarter Ending Dec-18 | 2 | 125,400.00 | 127,000.00 | 123,800.00 | -- |
| Year Ending Mar-18 | 9 | 438,040.00 | 449,846.00 | 432,800.00 | -- |
| Year Ending Mar-19 | 9 | 433,094.00 | 441,000.00 | 420,000.00 | 432,949.00 |
| Year Ending Mar-20 | 9 | 432,302.00 | 451,600.00 | 403,000.00 | 420,871.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 1 | 20.50 | 20.50 | 20.50 | -- |
| Quarter Ending Dec-18 | 1 | 22.30 | 22.30 | 22.30 | -- |
| Year Ending Mar-18 | 10 | 115.00 | 121.89 | 107.30 | -- |
| Year Ending Mar-19 | 10 | 94.23 | 116.10 | 78.80 | 129.19 |
| Year Ending Mar-20 | 10 | 93.82 | 114.80 | 59.50 | 114.78 |
| LT Growth Rate (%) | 1 | -1.44 | -1.44 | -1.44 | -3.97 |
Sales and Profit Figures in Japanese Yen (JPY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 21.98 | 30.95 | 32.74 | |
| P/E High - Last 5 Yrs. | 29.28 | 40.70 | 45.73 | |
| P/E Low - Last 5 Yrs. | 17.83 | 23.63 | 24.23 | |
| Beta | 0.26 | 0.89 | 0.88 | |
| Price to Sales (TTM) | 3.42 | 3.94 | 5.71 | |
| Price to Book (MRQ) | 1.68 | 4.81 | 5.37 | |
| Price to Tangible Book (MRQ) | 2.02 | 5.61 | 6.94 | |
| Price to Cash Flow (TTM) | 19.51 | 22.91 | 23.32 | |
| % Owned Institutions | -- | 1.21 | 2.17 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 2.00 | 1.56 | 1.50 | |
| Dividend Yield - 5 Year Avg | 2.38 | 1.57 | 1.51 | |
| Dividend 5 Year Growth Rate | 8.24 | 4.47 | 5.32 | |
| Payout Ratio(TTM) | 43.97 | 45.35 | 43.29 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 2.10 | 2.24 | 7.89 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -1.48 | 4.83 | 5.68 | |
| Sales - 5 Yr. Growth Rate | 0.81 | 10.08 | 10.33 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -22.47 | 16.38 | 19.38 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 5.78 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 12.81 | 9.88 | 10.78 | |
| Capital Spending - 5 Yr. Growth Rate | 14.25 | 15.52 | 15.47 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 7.39 | 2.12 | 2.19 |
| Current Ratio (MRQ) | 8.30 | 2.90 | 2.98 |
| LT Debt to Equity (MRQ) | 0.33 | 9.88 | 12.19 |
| Total Debt to Equity (MRQ) | 3.10 | 13.86 | 16.46 |
| Interest Coverage (TTM) | -- | 35.89 | 32.81 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 60.83 | 54.81 | 54.46 | |
| Gross Margin - 5 Yr. Avg. | 60.62 | 52.15 | 52.22 | |
| EBITD Margin (TTM) | 22.70 | -- | -- | |
| EBITD - 5 Yr. Avg | 21.22 | 18.57 | 10.98 | |
| Operating Margin (TTM) | 20.16 | 14.36 | 4.74 | |
| Operating Margin - 5 Yr. Avg. | 16.83 | 14.52 | 6.41 | |
| Pre-Tax Margin (TTM) | 20.59 | 14.82 | 5.58 | |
| Pre-Tax Margin - 5 Yr. Avg. | 18.22 | 14.91 | 6.83 | |
| Net Profit Margin (TTM) | 15.03 | 11.08 | 1.88 | |
| Net Profit Margin - 5 Yr. Avg. | 11.95 | 11.20 | 3.10 | |
| Effective Tax Rate (TTM) | 27.00 | 23.16 | 23.04 | |
| Effective Tax Rate - 5 Yr. Avg. | 34.42 | 23.42 | 23.95 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 58,542,860 | 938,104,300 | 846,855,748 | |
| Net Income/Employee (TTM) | 8,800,412 | 110,371,256 | 99,619,396 | |
| Receivable Turnover (TTM) | 3.33 | 5.63 | 5.78 | |
| Inventory Turnover (TTM) | 2.27 | 2.59 | 3.35 | |
| Asset Turnover (TTM) | 0.44 | 0.95 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 6.67 | 11.40 | 10.95 | |
| Return on Assets - 5 Yr. Avg. | 5.52 | 12.91 | 12.32 | |
| Return on Investment (TTM) | 7.37 | 14.84 | 14.38 | |
| Return on Investment - 5 Yr. Avg. | 6.20 | 16.88 | 16.11 | |
| Return on Equity (TTM) | 7.89 | 16.34 | 16.08 | |
| Return on Equity - 5 Yr. Avg. | 6.59 | 17.98 | 17.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -0.42 | 0.90 | 0.81 |
| EPS (TTM) % | 20.16 | 16.22 | 12.81 |
| Dividend % | 13.04 | 9.14 | 8.24 |
Note: Units in Millions of US Dollars
Performance for Mitsubishi Tanabe Pharma Corp
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -0.80 | -6.31 | 99 | 25 |
| 13 Week | -1.07 | -5.76 | 99 | 35 |
| 26 Week | 10.60 | -2.34 | 99 | 29 |
| 52 Week | 20.49 | -3.31 | 99 | 12 |
| YTD | 13.34 | 2.02 | 99 | 25 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 16.48% |
| # of Holders: | 244 |
| Total Shares Held: | 92,501,758 |
| 3 Mo. Net Change: | 17,918,536 |
| # New Positions: | 4 |
| # Closed Positions: | 8 |
| # Increased Positions: | 64 |
| # Reduced Positions: | 54 |
| # Net Buyers: | 10 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.